(833) 317-6278 
Dani Blum is a Health Reporter at The Times. She has extensively covered Covid-19 since the pandemic's onset and has reported on the implications of Ozempic since 2022, with a focus on medicine, healthcare, and wellness. Dani's work has been featured in numerous outlets, including The New York Times, The Sydney Morning Herald, and Yahoo News.
Preston's Summary
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Geo Focus
United States (National)
Coverage Attributes:
Beta
Cites Data:
46
%
How To Guide:
10
%
Expert Commentary:
7
%
Government Announcement:
6
%
Profile Feature:
4
%
Themes Covered:
Not enough data
Pitching Insights
Dani Blum’s coverage focuses heavily on healthcare, pharmaceuticals, and lifestyle topics. She frequently cites data in her articles, indicating a preference for evidence-based insights. Pitches should aim to offer credible research or expert opinions supported by data.
Given the focus on weight loss medications and health-related topics, experts from the medical field with experience in pharmacology, nutrition, or related specialties may find success when pitching to Dani. Additionally, pitches that tie into current trends in healthcare technology such as telehealth could also be of interest.
While Dani's geographic focus is national (United States), she covers a broad range of health-related topics which are not specific to any particular region within the US.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
